A human transporter protein that mediates the final excretion step for toxic organic cations
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
In mammals, toxic electrolytes of endogenous and exogenous origin are excreted through the urine and bile. Before excretion, these compounds cross numerous cellular membranes in a transporter-mediated manner. However, the protein transporters involved in the final excretion step are poorly understood. Here, we show that MATE1, a human and mouse orthologue of the multidrug and toxin extrusion family conferring multidrug resistance on bacteria, is primarily expressed in the kidney and liver, where it is localized to the luminal membranes of the urinary tubules and bile canaliculi. When expressed in HEK293 cells, MATE1 mediates H + -coupled electroneutral exchange of tetraethylammonium and 1-methyl-4-phenylpyridinium. Its substrate specificity is similar to those of renal and hepatic H + -coupled organic cations (OCs) export. Thus, MATE1 appears to be the long searched for polyspecific OC exporter that directly transports toxic OCs into urine and bile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Properties of Bacterial Multidrug Transporters
Putman, M., van Veen, H. W., & Konings, W. N. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.672-693.2000 · Cited by 795
Nawrath, C., Heck, S., Parinthawong, N., & Métraux, J.-P. (2002) · The Plant Cell · doi:10.1105/tpc.010376 · Cited by 604
Debeaujon, I., Peeters, A. J. M., Léon-Kloosterziel, K. M., & Koornneef, M. (2001) · The Plant Cell · doi:10.1105/tpc.13.4.853 · Cited by 553
Mechanisms mediating renal secretion of organic anions and cations
Pritchard, J. B., & Miller, D. S. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.4.765 · Cited by 490
Cloning and characterization of a novel human pH‐dependent organic cation transporter, OCTN1
Tamai, I., Yabuuchi, H., Nezu, J.-I., Sai, Y., Oku, A., Shimane, M., & Tsuji, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01441-5 · Cited by 458
Cellular and molecular aspects of drug transport in the kidney
Inui, K.-I., Masuda, S., & Saito, H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00251.x · Cited by 450
Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport
Wright, S. H., & Dantzler, W. H. (2004) · Physiological Reviews · doi:10.1152/physrev.00040.2003 · Cited by 404
Interstitial deletion of (17)(p11.2p11.2) in nine patients
Smith, A. C. M., McGavran, L., Robinson, J., Waldstein, G., Macfarlane, J., Zonona, J., Reiss, J., Lahr, M., Allen, L., Magenis, E., et al. (1986) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320240303 · Cited by 402
Morita, Y., Kodama, K., Shiota, S., Mine, T., Kataoka, A., Mizushima, T., & Tsuchiya, T. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1778 · Cited by 391
Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
Oude Elferink, R. P. J., Meijer, D. K. F., Kuipers, F., Jansen, P. L. M., Groen, A. K., & Groothuis, G. M. M. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(95)00006-d · Cited by 386
Cited by
Clinical pharmacokinetics of metformin
Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11534750-000000000-00000 · Cited by 1,318
“Multidrug and toxin extrusion transporter (MATE)-1 has been proposed to mediate the transport of metformin into bile canaliculus as it is present at this site and is a carrier of metformin.([48,49]) However, metformin is not present in faeces after intravenous administration although it is present after oral dosage (s…”
BackgroundKoepsell, H., Lips, K., & Volk, C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9254-z · Cited by 988
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
Klaassen, C. D., & Aleksunes, L. M. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002014 · Cited by 807
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
ABC transporter AtABCG25 is involved in abscisic acid transport and responses
Kuromori, T., Miyaji, T., Yabuuchi, H., Shimizu, H., Sugimoto, E., Kamiya, A., Moriyama, Y., & Shinozaki, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912516107 · Cited by 618
Self-citationHilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.-L., & Karlsson, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
König, J., Müller, F., & Fromm, M. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007518 · Cited by 575
Metformin pathways: pharmacokinetics and pharmacodynamics
Gong, L., Goswami, S., Giacomini, K. M., Altman, R. B., & Klein, T. E. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283559b22 · Cited by 495
Marinova, K., Pourcel, L., Weder, B., Schwarz, M., Barron, D., Routaboul, J.-M., Debeaujon, I., & Klein, M. (2007) · The Plant Cell · doi:10.1105/tpc.106.046029 · Cited by 482
The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
Hall, M. D., Okabe, M., Shen, D.-W., Liang, X.-J., & Gottesman, M. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.080907.180426 · Cited by 474
Chronic Kidney Disease and Exposure to Nephrotoxic Metals
Orr, S., & Bridges, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051039 · Cited by 434
The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations
Omote, H., Hiasa, M., Matsumoto, T., Otsuka, M., & Moriyama, Y. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.09.001 · Cited by 432
Self-citationTanihara, Y., Masuda, S., Sato, T., Katsura, T., Ogawa, O., & Inui, K.-I. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.010 · Cited by 417
Multidrug efflux transporters in the MATE family
Kuroda, T., & Tsuchiya, T. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.012 · Cited by 396
Nies, A. T., Koepsell, H., Damme, K., & Schwab, M. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_3 · Cited by 375
Masuda, S., Terada, T., Yonezawa, A., Tanihara, Y., Kishimoto, K., Katsura, T., Ogawa, O., & Inui, K.-I. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030205 · Cited by 371
Drug Transporters in Drug Efficacy and Toxicity
DeGorter, M. K., Xia, C. Q., Yang, J. J., & Kim, R. B. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134529 · Cited by 359
Hillgren, K. M., Keppler, D., Zur, A. A., Giacomini, K. M., Stieger, B., Cass, C. E., & Zhang, L. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.74 · Cited by 352
Tzvetkov, M. V., Vormfelde, S. V., Balen, D., Meineke, I., Schmidt, T., Sehrt, D., Sabolić, I., Koepsell, H., & Brockmöller, J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.92 · Cited by 349
Yonezawa, A., Masuda, S., Yokoo, S., Katsura, T., & Inui, K.-I. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110346 · Cited by 344
Renal Transporters in Drug Development
Morrissey, K. M., Stocker, S. L., Wittwer, M. B., Xu, L., & Giacomini, K. M. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140317 · Cited by 324
Organic Cation Transporters in Health and Disease
Koepsell, H. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015578 · Cited by 297
Becker, M. L., Visser, L. E., van Schaik, R. H. N., Hofman, A., Uitterlinden, A. G., & Stricker, B. H. C. (2009) · Diabetes · doi:10.2337/db08-1028 · Cited by 290
Chen, Y., Li, S., Brown, C., Cheatham, S., Castro, R. A., Leabman, M. K., Urban, T. J., Chen, L., Yee, S. W., Choi, J. H., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832cc7e9 · Cited by 248
“While OCT2 appears responsible for the entry of metformin into the renal tubular cells [3], recently identified transporters, multidrug and toxic compound extrusion proteins (MATEs) [20], may contributes to the flux of metformin from the tubule cells to the tubule lumen.”
Shoji, T., Inai, K., Yazaki, Y., Sato, Y., Takase, H., Shitan, N., Yazaki, K., Goto, Y., Toyooka, K., Matsuoka, K., et al. (2009) · Plant Physiology · doi:10.1104/pp.108.132811 · Cited by 234
“Proton-dependent antiport activity of MATE-family transporters has been shown for AtDTX1 (Li et al., 2002), FRD3 (Durrett et al., 2007), TT12 (Marinova et al., 2007), and hMATE1 (Otsuka et al., 2005).”
BackgroundKusuhara, H., Ito, S., Kumagai, Y., Jiang, M., Shiroshita, T., Moriyama, Y., Inoue, K., Yuasa, H., & Sugiyama, Y. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.36 · Cited by 217
Self-citationTzvetkov, M. V., dos Santos Pereira, J. N., Meineke, I., Saadatmand, A. R., Stingl, J. C., & Brockmöller, J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.019 · Cited by 206
“MATE1 mRNA expression was detectable, but MATE1 is expressed in the canalicular membrane only [39,40] and therefore cannot contribute to the morphine uptake from blood.”
BackgroundOrganic Cation Transporter OCTs (SLC22) and MATEs (SLC47) in the Human Kidney
Motohashi, H., & Inui, K.-I. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9465-7 · Cited by 199
“The transporter protein involved in the excretion step at tubular epithelia was identified as MATE1, a mammalian ortholog of the MATE family conferring multidrug resistance in bacteria (27).”
BackgroundYonezawa, A., & Inui, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01394.x · Cited by 197
“MATE1 and MATE2-K were predicted to have 12 or 13 transmembrane domains using in silico systems (Otsuka et al., 2005; Terada and Inui, 2008).”
BackgroundMethodInfluentialRenal drug transporters and their significance in drug–drug interactions
Yin, J., & Wang, J. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.07.013 · Cited by 195
Stocker, S. L., Morrissey, K. M., Yee, S. W., Castro, R. A., Xu, L., Dahlin, A., Ramirez, A. H., Roden, D. M., Wilke, R. A., McCarty, C. A., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.210 · Cited by 193
Transporter-Mediated Drug–Drug Interactions
Müller, F., & Fromm, M. F. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.44 · Cited by 172
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
Puris, E., Fricker, G., & Gynther, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020364 · Cited by 58
Progress in the Molecular Characterization of Hepatobiliary Transporters
Keppler, D. (2017) · Digestive Diseases · doi:10.1159/000450911 · Cited by 33
Principles of Alternating Access in Multidrug and Toxin Extrusion (MATE) Transporters
Claxton, D. P., Jagessar, K. L., & Mchaourab, H. S. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166959 · Cited by 29
Shi, R., Yang, Y., Xu, Z., Dai, Y., Zheng, M., Wang, T., Li, Y., & Ma, Y. (2018) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2112 · Cited by 14
“In addition, another important transporter, named multidrug and toxin extrusion 1 (MATE1), is also expressed in the apical side and plays an important role in the final excretion of organic cations (Otsuka et al., 2005).”
Background
Metadata
- Authors
- Otsuka, M., Matsumoto, T., Morimoto, R., Arioka, S., Omote, H., & Moriyama, Y.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-12-05
- Volume
- 102
- Issue
- 50
- Pages
- 17923-17928
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2034886511
- Cited by
- 571
- References
- 22
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.